Find (Foundation for Innovative New Diagnostics) has joined CPGR (Centre for Proteomic and Genomic Research) with the aim of helping to create a biotech hub in South Africa.
The CPGR is a not-for-profit organisation owned by its members.
These members aim to create relationships with stakeholders in the biotech sector.
The CPGR's immediate focus is in enabling translational research related to key African diseases such as TB, HIV/Aids and malaria.
Find, based in Geneva, Switzerland is a not-for-profit Swiss foundation that aims to drive the development and implementation of accurate and affordable diagnostic tests that can be used close to where patients first seek care.
Find's disease portfolio currently includes tuberculosis, malaria and human African trypanosomiasis.
Current donors are the Bill and Melinda Gates Foundation, the European Union, the government of the Netherlands, Unitaid, Irish Aid and other institutions and private donors.
Find is ISO 9001:2000 and ISO 13485:2003 certified.
